Tianjin Lisheng Pharmaceutical Co Ltd Free Cash Flow Generation Index
Tianjin Lisheng Pharmaceutical Co Ltd free cash flow generation index. Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Free Cash Flow Generation Index of 0.93x as of December 2025. Free cash flow of CN¥267.70 Million represents 1% of operating cash flow (CN¥287.81 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Free cash flow generation index of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. Historical FCF Generation Index trend for Tianjin Lisheng Pharmaceutical Co Ltd across 19 annual periods. See Tianjin Lisheng Pharmaceutical Co Ltd (002393) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Tianjin Lisheng Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2007–2025)
Tianjin Lisheng Pharmaceutical Co Ltd free cash flow generation index by year from 2007 to 2025. Year-by-year Free Cash Flow Generation Index for Tianjin Lisheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002393 cash flow metrics.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥414.39 Million | CN¥451.85 Million | CN¥37.46 Million | ▲ +134.5% |
| 2024 | 0.39x | CN¥34.51 Million | CN¥88.26 Million | CN¥53.75 Million | ▼ -40.8% |
| 2023 | 0.66x | CN¥138.29 Million | CN¥209.51 Million | CN¥61.72 Million | ▼ -24.7% |
| 2022 | 0.88x | CN¥290.47 Million | CN¥331.38 Million | CN¥40.91 Million | ▲ +59.2% |
| 2021 | 0.55x | CN¥108.10 Million | CN¥196.34 Million | CN¥88.24 Million | ▲ +273.1% |
| 2020 | -0.32x | CN¥-24.29 Million | CN¥76.37 Million | CN¥100.66 Million | ▼ -148.0% |
| 2019 | 0.66x | CN¥177.87 Million | CN¥268.33 Million | CN¥90.46 Million | ▲ +85.1% |
| 2018 | 0.36x | CN¥58.26 Million | CN¥162.69 Million | CN¥104.43 Million | ▼ -50.3% |
| 2017 | 0.72x | CN¥129.16 Million | CN¥179.25 Million | CN¥50.09 Million | ▲ +243.7% |
| 2016 | 0.21x | CN¥36.40 Million | CN¥173.60 Million | CN¥137.20 Million | ▲ +741.7% |
| 2015 | -0.03x | CN¥-6.47 Million | CN¥198.13 Million | CN¥204.60 Million | ▲ +98.9% |
| 2014 | -3.02x | CN¥-218.41 Million | CN¥72.24 Million | CN¥290.65 Million | ▼ -3627.3% |
| 2013 | -0.08x | CN¥-23.49 Million | CN¥289.62 Million | CN¥313.11 Million | ▼ -177.1% |
| 2012 | 0.11x | CN¥26.38 Million | CN¥250.72 Million | CN¥224.35 Million | ▲ +145.2% |
| 2011 | -0.23x | CN¥-31.36 Million | CN¥134.58 Million | CN¥165.94 Million | ▼ -137.2% |
| 2010 | 0.63x | CN¥116.87 Million | CN¥186.55 Million | CN¥69.69 Million | ▼ -31.2% |
| 2009 | 0.91x | CN¥178.55 Million | CN¥196.14 Million | CN¥17.60 Million | ▲ +86.7% |
| 2008 | 0.49x | CN¥61.73 Million | CN¥126.59 Million | CN¥64.86 Million | ▼ -47.0% |
| 2007 | 0.92x | CN¥161.02 Million | CN¥174.94 Million | CN¥13.92 Million | — |